Editorial: Novel and emerging therapies for the treatment of obesity and related disorders

Isabel R Amado; Marina Romaní-Pérez; Pablo Fuciños; Manuel Gil-Lozano

doi:10.3389/fendo.2024.1371113

Editorial: Novel and emerging therapies for the treatment of obesity and related disorders

Front Endocrinol (Lausanne). 2024 Apr 26:15:1371113. doi: 10.3389/fendo.2024.1371113. eCollection 2024.

Authors

Isabel R Amado¹, Marina Romaní-Pérez², Pablo Fuciños¹, Manuel Gil-Lozano^{3

4

5}

Affiliations

¹ International Iberian Nanotechnology Laboratory (INL), Braga, Portugal.
² Microbiome, Nutrition & Health Research Unit, Institute of Agrochemistry and Food Technology, Severo Ochoa Centre of Excellence, National Research Council (IATA-CSIC), Valencia, Spain.
³ Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
⁴ Joint Heidelberg-Institute for Diabetes and Cancer (IDC) Translational Diabetes Program, Inner Medicine, Heidelberg University Hospital, Heidelberg, Germany.
⁵ German Center for Diabetes Research (DZD), Neuherberg, Germany.

No abstract available

Keywords: body composition; brown adipose tissue (BAT); exercise mimetics; extracellular vesicles; insulin resistance; intestinal inflammation; microbiota; obesity.

Publication types

Editorial
Introductory Journal Article
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Humans
Obesity* / therapy